0000315545 2023-01-01 2023-12-31 0000315545 2023-06-30 0000315545 2024-04-24 iso4217:USD shares iso4217:USD shares true FY 0000315545 10-K/A true 2023-12-31 --12-31 2023 false 001-36457 PROVECTUS BIOPHARMACEUTICALS, INC. DE 90-0031917 10025 Investment Drive Suite 250 Knoxville TN 37932 866 594-5999 No No Yes Yes Non-accelerated Filer true false false false false 45528616 419522119 Marcum LLP Los Angeles, CA 688 This Amendment No. 1 on Form 10-K/A (this “Amendment”) amends the Annual Report on Form 10-K of Provectus Biopharmaceuticals, Inc. (the “Company,” “our,” “us” or “we,” unless the context indicates otherwise) for the year ended December 31, 2023, originally filed with the U.S. Securities and Exchange Commission (“SEC”) on March 28, 2024 (the “Original Filing”).